Microba Life Sciences Signs Partnership With Nib-Backed Midnight Health

  • Partnership agreement signed with Midnight Health to deliver a world-first personalised consumer health service called Vidality
  • Midnight Health will promote, market and sell a new subscription consumer health service driven by Microba’s core technology
  • nib-backed Midnight Health is a fast growth, Australian-based, digital healthcare company

Microba Life Sciences Limited has signed a strategic partnership agreement with nib Holdings Limited backed digital healthcare company Midnight Health, to deliver a personalised health service to the Australian consumer market.

Under this Agreement, Midnight Health will promote, market and sell a world-first subscription-based service, known as Vidality, with its network of pharmacists to formulate personalised supplements for each customer based on their microbiome test results, leveraging the recommendations from Microba’s Analysis Platform.

This personalised, pharmacy-integrated service model – delivered with trained, registered pharmacists – will bring a level of science and personalisation to an industry which commonly provides customers with one-size-fits-all solutions.

“We are experiencing strong demand for innovative online healthcare solutions aligned to an individual needs. We already have more than 13,000 subscribers across our existing brands with strong month-on-month growth. Many of our customers are looking for gut health solutions and we are proud to bring the Vidality product to our customers in partnership with Microba”.

Midnight Health CEO, Nic Blair

The Agreement was signed, for an initial period of 3 years, after a successful pilot which tested the service model and product offering. It further demonstrates Microba’s scalable technology and ability to deliver evidence-based gut health solutions together with distribution partners.

“Consumers are seeking personalised, evidence-based solutions to support their gut health. Together with Midnight Health, we are excited to bring the Vidality product to consumers, a truly personalised solution powered by our technology”.

Microba CEO, Dr Luke Reid

This delivers on an undertaking in the Company’s Prospectus to enter into an Australian partnership with a fast growth innovative consumer healthcare company.

Next Post

NextGen Healthcare Launches Health Data Hub Insights

NextGen Healthcare, Inc., a leading provider of innovative, cloud-based healthcare technology solutions, announced today the launch of NextGen® Health Data Hub Insights – a modern and extensible data warehouse and custom analytics solution. The tool is designed to simplify data access, analytics and report generation for health information exchanges (HIEs) […]